drugset / Trial / NCT07241949

External Oblique Intercostal Block (EOICB) for Laparoscopic Cholecystectomy

NCT07241949

Recruiting 147 enrolled Cukurova University
RandomizedParallel-groupSingle-blindTreatment

Summary

This single-center, prospective, randomized controlled trial aims to compare the effects of paravertebral block (PVB), external oblique intercostal (EOI) block, and intravenous patient-controlled analgesia (PCA) with tramadol on postoperative pain and opioid consumption in patients undergoing elective laparoscopic cholecystectomy. The primary endpoint is total tramadol consumption within 24 hours postoperatively. Secondary outcomes include pain scores, additional analgesic use, incidence of nausea/vomiting, mobilization time, and length of hospital stay.

Timeline

Start
2025-12-01
Primary completion
2026-11-01
Completion
2026-12-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tramadol Other / unclassified 400 mg Intravenous

Indications

No indication recorded.